Argyle launches new integration, bringing real-time income and employment verification to Byte LOS customers
- New integration accelerates loan processing, enhances loan quality and embeds verification in the loan origination workflow -
NEW YORK CITY, N.Y., May 20, 2025 (SEND2PRESS NEWSWIRE) — Argyle, a platform providing automated income and employment verifications for some of the largest lenders in the United States, today announced a new integration with Byte Software 's loan origination system (LOS). The integration enables lenders to access Argyle's real-time verification of income and employment (VOIE) services directly within the Byte platform, ensuring verification happens when and where it's needed to improve loan quality and keep loans moving forward.
Argyle verifies income and employment through secure connections with the borrower's employer or payroll provider. With real-time access to payroll data, Byte users can generate verification reports that reflect the most current income and employment data available throughout the loan process.
'Our integration with Byte gives lenders access to GSE-approved, consumer-permissioned income and employment data and documents at a significantly lower price point than legacy solutions,' said John Hardesty, vice president of Argyle's mortgage division. 'Income and employment verifications in the Byte loan origination system gives lenders an edge in a competitive market, ensuring loans move forward efficiently with accurate, up-to-date income and employment data.'
Mark Todd, Byte's EVP of sales and client services, shared similar sentiments: 'We are thrilled to partner with Argyle to bring real-time income and employment verification to our platform. This integration aligns with our commitment to providing our clients with innovative technology solutions that enhance the borrower experience and streamline the loan origination process.'
For more information about Argyle's LOS integrations, visit https://argyle.com/use-cases/loan-origination-systems.
About Argyle:
Argyle is the leading provider of direct-source, consumer-permissioned income and employment verifications, making it fast and easy to gain secure and reliable access to the most complete real-time datasets stored in consumers' payroll accounts. With Argyle, lenders automate verification workflows to save time, reduce fraud and compliance risks, lower costs, and build better product experiences. As an authorized report supplier for Fannie Mae's Desktop Underwriter® validation service and an approved service provider supporting Freddie Mac's Loan Product Advisor® asset and income modeler (AIM), Argyle empowers mortgage lenders to auto-retrieve paystubs and W-2s, understand consumers' ability to pay and improve loan quality – all at 80% less cost. Argyle's commitment to innovation is backed by investors including Bain Capital Ventures, SignalFire, Checkr and Rockefeller Asset Management. For more information on Argyle's industry-leading VOIE platform, visit https://argyle.com/
Tags: @withArgyle #mortgage #lending
NEWS SOURCE: Argyle
###
MEDIA ONLY CONTACT:
(not for publication online or in print)
Leslie W. Colley
Depth for Argyle
[email protected]
(678) 622-6229
- and -
Robert Palmer
Byte Software
[email protected]
REQUEST A DEMO: https://bytesoftware.com/
###
Keywords: Finance, ARGYLE automated income and employment verifications, Byte Software, fintech, VOIE, loan origination system, NEW YORK CITY, N.Y.
This press release was issued on behalf of the news source (Argyle) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P126291 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/argyle-launches-new-integration-bringing-real-time-income-and-employment-verification-to-byte-los-customers/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)-- SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; 'Modalis'), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM ® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM ® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. 'SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD,' stated Eva Chin, Executive Director of SOLVE FSHD. 'SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials.' 'We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103,' said Haru Morita, CEO of Modalis. 'This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM ® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM ® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD.' About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM ® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit
Yahoo
2 hours ago
- Yahoo
EthicAI Advisory Limited: Cambridge spinout launches new tool to boost confidence in AI
LONDON, June 9, 2025 /PRNewswire/ -- EthicAI Advisory Limited ("EthicAI"), a University of Cambridge spinout and global leader in the ethical and responsible assurance of artificial intelligence, has launched a cloud-based AI assurance SaaS platform to address ethical and trust issues around the adoption of AI, unlocking the technology's economic potential. AI models can create problems across a number of areas: Fairness and bias — AI systems can discriminate against certain groups including through hidden bias in training data Transparency — automating workflows can create 'black box' issues where algorithmic decision-making is opaque and consequently hard to understand and challenge Employee impacts — automation may unintentionally disempower, not augment, human workers if not designed carefully. The adoption of AI without enablement and literacy programmes can also erode company culture and employee motivation BeehAIve® scrutinises models and datasets against 15 ethical dimensions, assessing evidence across thousands of measurement points. The platform allows organisations to design, deploy and monitor autonomous systems that are optimised for success. BeehAIve® allows for technical stress-testing of model performance to improve reliability, robustness and security, while also recommending ways to reduce energy usage from AI. The platform enables assessment of models and systems against regional and national legislation including the EU AI Act, GDPR, the Korean AI Act, as well as industry-specific regulations and globally recognised AI standards. BeehAIve® then recommends how gaps can be filled, preparing for cross-border compliance while building stakeholder trust. The platform offers organisations a secure hub for their AI data, ensuring information remains safe and encrypted at all times. Tanya Goodin, Founder & CEO of EthicAI says: "BeehAIve® is a unique platform that enables organisations and their stakeholders to adopt AI with increased trust and confidence. Research shows that consumer confidence in AI has fallen by 8% globally over the past five years due to concerns about how AI is designed and built. BeehAIve® looks under the hood of organisations' AI models and systems — both in development and post deployment — to identify blind spots and weaknesses and provides actionable insights on how to mitigate and manage risks." For further information, contact: tanya@ or tim@ EthicAI Advisory Ltd EthicAI was formed in 2022 to build trust in AI by assuring models and systems to the highest ethical and responsible standards. EthicAI spun out of the University of Cambridge's Leverhulme Centre for the Future of Intelligence, with all the founding team previously engaged in cutting-edge AI ethics research at the university. The founders' leadership experience spans organisations including the BBC, Fidelity Investments, Barclays, Merrill Lynch, Deutsche Bank and UBS. Read more about the team here. EthicAI's cloud-based platform BeehAIve® will allow the company to scale its offer, and bring solutions to more organisations, more rapidly. It sits at the heart of the company's mission to ensure the ethical and responsible adoption of state-of-the-art AI systems — powering their success and helping to strengthen the UK's position as a leader in artificial intelligence. View original content: Sign in to access your portfolio
CNBC
15 hours ago
- CNBC
What a ‘revenge tax' in Trump's spending bill could mean for investors
As the Senate weighs President Donald Trump's multi-trillion-dollar spending package, a lesser-known provision tucked into the House-approved bill has pushback from Wall Street. The House measure, known as Section 899, would allow the U.S. to add a new tax of up to 20% on foreigners with U.S. investments, including multinational companies operating in the U.S. Some analysts call the provision a "revenge tax" due to its wording. It would apply to foreign entities if their home country imposes "unfair foreign taxes" against U.S. companies, according to the bill. "Wall Street investors are shocked by [Section] 899 and apparently did not see it coming," James Lucier, Capital Alpha Partners managing director, wrote in a June 5 analysis. More from Personal Finance:The average 401(k) savings rate hit a record high. See if you're on trackOn-time debt payments aren't a magic fix for your credit score. Here's whyWith 'above normal' hurricane forecasts, check your home insurance policy If enacted as written, the provision could have "significant implications for the asset management industry," including cross-border income earned by hedge funds, private equity funds and other entities, Ernst & Young wrote on June 2. Passive investment income could be subject to a higher U.S. withholding tax, as high as 50% in some cases, the company noted. Some analysts worry that could impact future investment. The Investment Company Institute, which represents the asset management industry serving individual investors, warned in a May 30 statement that the provision is "written in a manner that could limit foreign investment to the U.S." But with details pending as the Senate assesses the bill, many experts are still weighing the potential impact — including who could be affected. Here's what investors need to know about Section 899. As drafted, Section 899 would allow the U.S. to hike existing levies for countries with "unfair foreign taxes" by 5% per year, capped at 20%. Several kinds of tax fall under "unfair foreign taxes," according to the provision. Those include the undertaxed profits rule, which is associated with part of the global minimum tax negotiated by the Biden administration. The term would also apply to digital services taxes and diverted profits taxes, along with new levies that could arise, according to the bill. The second part of the measure would expand the so-called base erosion and anti-abuse tax, or BEAT, which aims to prevent corporations from shifting profits abroad to avoid taxes. "Basically, all businesses that are operating in the U.S. from a foreign headquarters will face that," said Daniel Bunn, president and CEO of the Tax Foundation. "It's pretty expansive." The retaliatory measures would apply to most wealthy countries from which the U.S. receives direct foreign investment, which could threaten or harm the U.S. economy, according to Bunn's analysis. Notably, the proposed taxes don't apply to U.S. Treasuries or portfolio interest, according to the bill. Section 899 still needs Senate approval, and it's unclear how the provision could change amid alarm from Wall Street. But the measure has "strong support" from others in the business community, and it's a "strong priority" for Republican House Ways and Means Committee members, Capital Alpha Partners' Lucier wrote. House Ways and Means Committee Chairman Jason Smith, R-Mo., first floated the idea in a May 2023 bill, and has been outspoken, along with other Republicans, against the global minimum tax. If enacted as drafted, Section 899 could raise an estimated $116 billion over 10 years, according to the Joint Committee on Taxation. That could help fund other priorities in Trump's mega-bill, and if removed, lawmakers may need to find the revenue elsewhere, Bunn said. However, House Ways and Means Republicans may ultimately want foreign countries to adjust their tax policies before the new tax is imposed. "If these countries withdraw these taxes and decide to behave, we will have achieved our goal," Smith said in a June 4 statement.
